Literature DB >> 577897

Reduction of plasma triiodothyronine (T3) induced by propranolol.

G Lotti, G Delitala, L Devilla, S Alagna, A Masala.   

Abstract

The effect of propranolol on plasma triiodothyronine (T3), thyroxine (T4) and triiodothyronine uptake by Sephadex G-25 (RT3U%) was studied in fourteen thyrotoxic patients and eight normal volunteers. 40 mg of propranolol as a single oral dose caused significant reduction in total serum T3 which began 60 min after administration. No significant changes were observed in T4 and RT3U% values. Plasma T3 levels remained suppressed during a 5 day course of treatment with propranolol. These results suggest that propranolol has a direct effect on peripheral metabolism of T3 rather than on thyroid hormone secretion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 577897     DOI: 10.1111/j.1365-2265.1977.tb03322.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  17 in total

1.  Beta-adrenergic blocking drugs and thyroid function.

Authors: 
Journal:  Br Med J       Date:  1977-10-22

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 3.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

4.  A study of long acting propranolol in the early management of hyperthyroidism.

Authors:  G R Jones; J H Lazarus; D Wynford-Thomas
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

5.  Beta 2-adrenoceptor agonists and thyroid hormones.

Authors:  J P Kampmann; T L Svendsen; L Skovsted; J E Mølholm Hansen
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

6.  Beta-adrenoreceptor blocking drugs and thyroid hormones in hyperthyroid subjects.

Authors:  M K Jones; J Birtwell; D R Owens; G R Jones; M Lewis
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

7.  D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine.

Authors:  P Heyma; R G Larkins; L Higginbotham; K W Ng
Journal:  Br Med J       Date:  1980-07-05

Review 8.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

9.  "Low T3-syndrome" in acute myocardial infarction--relationship to beta-adrenergic blockade and clinical course.

Authors:  F Pedersen; H Perrild; S L Rasmussen; L Skovsted
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Acute effect of atenolol on serum thyroid hormones in hyperthyroid patients.

Authors:  S Rassu; A Masala; S Alagna; P P Rovasio; M Langer
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.